Detection of CMV DNA in peripheral blood leukocytes as a long-range harbinger of CMV disease in HIV-infected patients. Swiss HIV Cohort Study.

about

Detection of CMV DNA in peripheral blood leukocytes as a long-range harbinger of CMV disease in HIV-infected patients. Swiss HIV Cohort Study.

Item

http://www.wikidata.org/entity/Q40785138

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

Detection of CMV DNA in periph ...... ients. Swiss HIV Cohort Study.

@en

type

Item

label

Detection of CMV DNA in periph ...... ients. Swiss HIV Cohort Study.

@en

prefLabel

Detection of CMV DNA in periph ...... ients. Swiss HIV Cohort Study.

@en

P1476

Detection of CMV DNA in periph ...... tients. Swiss HIV Cohort Study

@en

P2093

Barbani MT

http://www.w3.org/2001/XMLSchema#string

Meylan PR

http://www.w3.org/2001/XMLSchema#string

Muheim CR

http://www.w3.org/2001/XMLSchema#string

Rudaz PR

http://www.w3.org/2001/XMLSchema#string

P2860

Cicatrization of cytomegalovirus retinitis following introduction of highly active anti-retroviral therapy: uveitis as a possible indicator of good ocular prognosis.

The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics.

Viral dynamics of HIV: implications for drug development and therapeutic strategies.

Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.

Cytomegalovirus disease in AIDS.

Predictive value of cytomegalovirus (CMV) antigenemia and digene hybrid capture DNA assays for CMV disease in human immunodeficiency virus-infected patients.

Risk for retinitis in patients with AIDS can be assessed by quantitation of threshold levels of cytomegalovirus DNA burden in blood.

Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.

P304

147-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1076/OCII.7.3.147.4001

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roland Sahli

Katia Jaton

P577

1999-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10611722

http://www.w3.org/2001/XMLSchema#string

P921

HIV